Balentine LLC’s Qiagen QGEN Stock Holding History

Balentine LLC’s Portfolio QGEN Stock Details QGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-4,013	Closed	-$211K	–	685
2022 Q1	$211K	Buy	+4,013	New	+$207K	0.01%	537
2020 Q3	–	Sell	-517	Closed	-$24K	–	683
2020 Q2	$24K	Buy	+517	New	+$23.1K	﹤0.01%	358
2019 Q4	–	Sell	-166	Closed	-$6K	–	715
2019 Q3	$6K	Sell	166 -89	-35%	-$3.42K	﹤0.01%	491
2019 Q2	$11K	Buy	255 +89	+54%	+$3.69K	﹤0.01%	298
2019 Q1	$7K	Hold	166	–	–	﹤0.01%	338
2018 Q4	$6K	Buy	+166	New	+$6.17K	﹤0.01%	352

Other funds holding QGEN

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Balentine LLC's QGEN Position: Q2 2022 in Review

Balentine LLC sold out of Qiagen (QGEN) in Q2 2022, closing a stake of 4,013 shares — an estimated $211K sold.

Balentine LLC first reported a position in QGEN in Q4 2018 and held it in 6 quarters. The position peaked at $211K in Q1 2022. 287 funds tracked by Wall St. Rank hold QGEN as of Q2 2022.

Balentine LLC reported no remaining Qiagen position as of Q2 2022 after selling out during the quarter.
Balentine LLC sold 4,013 Qiagen shares in Q2 2022, an estimated $211K.
Balentine LLC first reported a position in Qiagen in Q4 2018 and held it in 6 quarters.
Balentine LLC's Qiagen position peaked at $211K in Q1 2022.
287 funds tracked by Wall St. Rank held Qiagen as of Q2 2022.

Based on Balentine LLC's 13F filing for Q2 2022, filed 15 Aug 2022.